BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li C, Zhang F, Shi L, Zhang H, Tian Z, Xie J, Jiang H. Nesfatin-1 Decreases Excitability of Dopaminergic Neurons in the Substantia Nigra. J Mol Neurosci 2014;52:419-24. [DOI: 10.1007/s12031-013-0169-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Emir GK, Ünal Y, Yılmaz N, Tosun K, Kutlu G. The association of low levels of nesfatin-1 and glucagon-like peptide-1 with oxidative stress in Parkinson’s disease. Neurol Sci 2019;40:2529-35. [DOI: 10.1007/s10072-019-03975-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
2 Chang X, Ma Z, Shi L, Xie J. Effects of ghrelin on the electrical activities of substantia nigra dopaminergic neurons treated with MPP.. Neurochem Int 2020;138:104780. [PMID: 32569790 DOI: 10.1016/j.neuint.2020.104780] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Rupp SK, Wölk E, Stengel A. Nesfatin-1 Receptor: Distribution, Signaling and Increasing Evidence for a G Protein-Coupled Receptor - A Systematic Review. Front Endocrinol (Lausanne) 2021;12:740174. [PMID: 34566899 DOI: 10.3389/fendo.2021.740174] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Chen X, Dong J, Jiao Q, Du X, Bi M, Jiang H. "Sibling" battle or harmony: crosstalk between nesfatin-1 and ghrelin. Cell Mol Life Sci 2022;79:169. [PMID: 35239020 DOI: 10.1007/s00018-022-04193-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Dong D, Xie J, Wang J. Neuroprotective Effects of Brain-Gut Peptides: A Potential Therapy for Parkinson's Disease. Neurosci Bull 2019;35:1085-96. [PMID: 31286411 DOI: 10.1007/s12264-019-00407-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
6 Liu M, Jiao Q, Du X, Bi M, Chen X, Jiang H. Potential Crosstalk Between Parkinson's Disease and Energy Metabolism. Aging Dis 2021;12:2003-15. [PMID: 34881082 DOI: 10.14336/AD.2021.0422] [Reference Citation Analysis]
7 Ashtari-Tavandashti T, Zendehdel M, Rahnema M, Hassanpour S, Asle-Rousta M. Possible interaction of central noradrenergic, serotoninergic and oxytocin systems with nesfatin-1 induced hypophagia and feeding behavior in newborn broiler. Peptides 2022;153:170803. [PMID: 35490830 DOI: 10.1016/j.peptides.2022.170803] [Reference Citation Analysis]
8 Chen H, Li X, Ma H, Zheng W, Shen X. Reduction in Nesfatin-1 Levels in the Cerebrospinal Fluid and Increased Nigrostriatal Degeneration Following Ventricular Administration of Anti-nesfatin-1 Antibody in Mice. Front Neurosci 2021;15:621173. [PMID: 33613183 DOI: 10.3389/fnins.2021.621173] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Erken HA, Koç ER, Erken G, Genç O, Çelik HT, Gökçe EC, Ayada C, Turgut S, Turgut G. Proconvulsant Effect of NUCB2/Nesfatin-1. Int J Pept Res Ther 2015;21:29-38. [DOI: 10.1007/s10989-014-9428-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
10 Abbasi Z, Khaksari M, Shayannia A, Jafarisani M, Abbaszadeh-goudarzi G, Nazarnezhad S, Rahmati M. Protection of the PC12 Cells by Nesfatin-1 Against Methamphetamine-Induced Neurotoxicity. Int J Pept Res Ther 2022;28. [DOI: 10.1007/s10989-022-10417-x] [Reference Citation Analysis]
11 Stengel A. Nesfatin-1 – More than a food intake regulatory peptide. Peptides 2015;72:175-83. [DOI: 10.1016/j.peptides.2015.06.002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
12 Tan Z, Xu H, Shen X, Jiang H. Nesfatin-1 antagonized rotenone-induced neurotoxicity in MES23.5 dopaminergic cells. Peptides 2015;69:109-14. [DOI: 10.1016/j.peptides.2015.04.019] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
13 Dore R, Krotenko R, Reising JP, Murru L, Sundaram SM, Di Spiezio A, Müller-Fielitz H, Schwaninger M, Jöhren O, Mittag J, Passafaro M, Shanabrough M, Horvath TL, Schulz C, Lehnert H. Nesfatin-1 decreases the motivational and rewarding value of food. Neuropsychopharmacology 2020;45:1645-55. [PMID: 32353862 DOI: 10.1038/s41386-020-0682-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
14 Psilopanagioti A, Makrygianni M, Nikou S, Logotheti S, Papadaki H. Nucleobindin 2/nesfatin-1 expression and colocalisation with neuropeptide Y and cocaine- and amphetamine-regulated transcript in the human brainstem. J Neuroendocrinol 2020;32:e12899. [PMID: 32902020 DOI: 10.1111/jne.12899] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Chen X, Shu X, Cong ZK, Jiang ZY, Jiang H. Nesfatin-1 acts on the dopaminergic reward pathway to inhibit food intake. Neuropeptides. 2015;53:45-50. [PMID: 26299312 DOI: 10.1016/j.npep.2015.07.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
16 Shen XL, Song N, Du XX, Li Y, Xie JX, Jiang H. Nesfatin-1 protects dopaminergic neurons against MPP+/MPTP-induced neurotoxicity through the C-Raf-ERK1/2-dependent anti-apoptotic pathway. Sci Rep 2017;7:40961. [PMID: 28106099 DOI: 10.1038/srep40961] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
17 Dore R, Levata L, Lehnert H, Schulz C. Nesfatin-1: functions and physiology of a novel regulatory peptide. Journal of Endocrinology 2017;232:R45-65. [DOI: 10.1530/joe-16-0361] [Cited by in Crossref: 64] [Cited by in F6Publishing: 20] [Article Influence: 12.8] [Reference Citation Analysis]